Phio Pharmaceuticals Corp.
- Last sale
- Nov 12, 2026 · -5.08%
- Market cap
- $9.56M
- 11.95M shares
- Filings
- 899
FY 2020−100.0% FY20 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q2 2025N/M FY24 yoy
Q3 2026+290.8% FY25 yoy
- $9.56M
- —
- —
- 1.1×
- -83.57%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2019 | 2019-12-31 | $21,000 | reported | |
| FY 2018 | 2018-12-31 | $138,000 | reported | |
| FY 2017 | 2017-12-31 | $15,000 | reported | |
| FY 2016 | 2016-12-31 | $19,000 | reported | |
| FY 2015 | 2015-12-31 | $34,000 | reported | |
| FY 2013 | 2013-12-31 | $399,000 | reported | |
| FY 2012 | 2012-12-31 | $97,000 | reported |
Pharmaceutical preparations
Phio Pharmaceuticals Corp. is the 419th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
BFRGBullFrog AI Holdings, Inc.$116.7K—5,569.6%$10.5MCMMBChemomab Therapeutics Ltd.———$10.1MDAREDare Bioscience, Inc.———$9.9MGDTCCytoMed Therapeutics Ltd$252.3K395.9%1,227.1%$9.8M
PHIOPhio Pharmaceuticals Corp. (this company)———$9.6M
INBPIntegrated Biopharma Inc$43.9M19.3%6.5%$9.1MAEMDAethlon Medical Inc———$8.8MRKTORocket One Inc.———$8.8MMTVAMetaVia Inc.———$8.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR